世界の勃起不全治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Erectile Dysfunction Treatment Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5727
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、勃起不全治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ホスホジエステラーゼ5型阻害剤、プロスタグランジンE1）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・勃起不全治療薬の市場動向
・企業の競争状況、市場シェア
・勃起不全治療薬の種類別市場規模と予測2016-2027（ホスホジエステラーゼ5型阻害剤、プロスタグランジンE1）
・勃起不全治療薬の用途別市場規模と予測2016-2027（病院、診療所、その他）
・勃起不全治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・勃起不全治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・勃起不全治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・勃起不全治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・勃起不全治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer Inc.、Dong-A Pharmaceutical Co. Ltd、Vivus, Inc.、Meda Pharmaceuticals、Bayer AG、Johnson & Johnson Services、Apricus Biosciences、Eli Lilly）
・結論

Erectile dysfunction is a very common sexual problem affecting 100 million people worldwide. It is often contributed by neurological disorders, cardiovascular diseases, diabetes, hormonal imbalance and obesity. The incidence of erectile dysfunction is also proportionate to ageing, along with being associated with certain risk factors such as usage of tobacco and alcohol, certain medications and medical treatment, injuries and psychological conditions.

Market Analysis and Insights: Global Erectile Dysfunction Treatment Drugs Market
The global Erectile Dysfunction Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Erectile Dysfunction Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Erectile Dysfunction Treatment Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Erectile Dysfunction Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Erectile Dysfunction Treatment Drugs market.

Global Erectile Dysfunction Treatment Drugs Scope and Market Size
Erectile Dysfunction Treatment Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Erectile Dysfunction Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Phosphodiesterase Type 5 Inhibitors
Prostaglandin E1

Segment by Application
Hospitals
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer Inc.
Dong-A Pharmaceutical Co. Ltd
Vivus, Inc.
Meda Pharmaceuticals
Bayer AG
Johnson & Johnson Services
Apricus Biosciences
Eli Lilly

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Erectile Dysfunction Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Phosphodiesterase Type 5 Inhibitors
1.2.3 Prostaglandin E1
1.3 Market by Application
1.3.1 Global Erectile Dysfunction Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Erectile Dysfunction Treatment Drugs Market Perspective (2016-2027)
2.2 Erectile Dysfunction Treatment Drugs Growth Trends by Regions
2.2.1 Erectile Dysfunction Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Erectile Dysfunction Treatment Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Erectile Dysfunction Treatment Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Erectile Dysfunction Treatment Drugs Industry Dynamic
2.3.1 Erectile Dysfunction Treatment Drugs Market Trends
2.3.2 Erectile Dysfunction Treatment Drugs Market Drivers
2.3.3 Erectile Dysfunction Treatment Drugs Market Challenges
2.3.4 Erectile Dysfunction Treatment Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Erectile Dysfunction Treatment Drugs Players by Revenue
3.1.1 Global Top Erectile Dysfunction Treatment Drugs Players by Revenue (2016-2021)
3.1.2 Global Erectile Dysfunction Treatment Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Erectile Dysfunction Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Erectile Dysfunction Treatment Drugs Revenue
3.4 Global Erectile Dysfunction Treatment Drugs Market Concentration Ratio
3.4.1 Global Erectile Dysfunction Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Erectile Dysfunction Treatment Drugs Revenue in 2020
3.5 Erectile Dysfunction Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Erectile Dysfunction Treatment Drugs Product Solution and Service
3.7 Date of Enter into Erectile Dysfunction Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Erectile Dysfunction Treatment Drugs Breakdown Data by Type
4.1 Global Erectile Dysfunction Treatment Drugs Historic Market Size by Type (2016-2021)
4.2 Global Erectile Dysfunction Treatment Drugs Forecasted Market Size by Type (2022-2027)

5 Erectile Dysfunction Treatment Drugs Breakdown Data by Application
5.1 Global Erectile Dysfunction Treatment Drugs Historic Market Size by Application (2016-2021)
5.2 Global Erectile Dysfunction Treatment Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Erectile Dysfunction Treatment Drugs Market Size (2016-2027)
6.2 North America Erectile Dysfunction Treatment Drugs Market Size by Type
6.2.1 North America Erectile Dysfunction Treatment Drugs Market Size by Type (2016-2021)
6.2.2 North America Erectile Dysfunction Treatment Drugs Market Size by Type (2022-2027)
6.2.3 North America Erectile Dysfunction Treatment Drugs Market Size by Type (2016-2027)
6.3 North America Erectile Dysfunction Treatment Drugs Market Size by Application
6.3.1 North America Erectile Dysfunction Treatment Drugs Market Size by Application (2016-2021)
6.3.2 North America Erectile Dysfunction Treatment Drugs Market Size by Application (2022-2027)
6.3.3 North America Erectile Dysfunction Treatment Drugs Market Size by Application (2016-2027)
6.4 North America Erectile Dysfunction Treatment Drugs Market Size by Country
6.4.1 North America Erectile Dysfunction Treatment Drugs Market Size by Country (2016-2021)
6.4.2 North America Erectile Dysfunction Treatment Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Erectile Dysfunction Treatment Drugs Market Size (2016-2027)
7.2 Europe Erectile Dysfunction Treatment Drugs Market Size by Type
7.2.1 Europe Erectile Dysfunction Treatment Drugs Market Size by Type (2016-2021)
7.2.2 Europe Erectile Dysfunction Treatment Drugs Market Size by Type (2022-2027)
7.2.3 Europe Erectile Dysfunction Treatment Drugs Market Size by Type (2016-2027)
7.3 Europe Erectile Dysfunction Treatment Drugs Market Size by Application
7.3.1 Europe Erectile Dysfunction Treatment Drugs Market Size by Application (2016-2021)
7.3.2 Europe Erectile Dysfunction Treatment Drugs Market Size by Application (2022-2027)
7.3.3 Europe Erectile Dysfunction Treatment Drugs Market Size by Application (2016-2027)
7.4 Europe Erectile Dysfunction Treatment Drugs Market Size by Country
7.4.1 Europe Erectile Dysfunction Treatment Drugs Market Size by Country (2016-2021)
7.4.2 Europe Erectile Dysfunction Treatment Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size (2016-2027)
8.2 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Type
8.2.1 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Application
8.3.1 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Region
8.4.1 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Erectile Dysfunction Treatment Drugs Market Size (2016-2027)
9.2 Latin America Erectile Dysfunction Treatment Drugs Market Size by Type
9.2.1 Latin America Erectile Dysfunction Treatment Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Erectile Dysfunction Treatment Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Erectile Dysfunction Treatment Drugs Market Size by Type (2016-2027)
9.3 Latin America Erectile Dysfunction Treatment Drugs Market Size by Application
9.3.1 Latin America Erectile Dysfunction Treatment Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Erectile Dysfunction Treatment Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Erectile Dysfunction Treatment Drugs Market Size by Application (2016-2027)
9.4 Latin America Erectile Dysfunction Treatment Drugs Market Size by Country
9.4.1 Latin America Erectile Dysfunction Treatment Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Erectile Dysfunction Treatment Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size (2016-2027)
10.2 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Type
10.2.1 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Application
10.3.1 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Country
10.4.1 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Erectile Dysfunction Treatment Drugs Introduction
11.1.4 Pfizer Inc. Revenue in Erectile Dysfunction Treatment Drugs Business (2016-2021)
11.1.5 Pfizer Inc. Recent Development
11.2 Dong-A Pharmaceutical Co. Ltd
11.2.1 Dong-A Pharmaceutical Co. Ltd Company Details
11.2.2 Dong-A Pharmaceutical Co. Ltd Business Overview
11.2.3 Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Drugs Introduction
11.2.4 Dong-A Pharmaceutical Co. Ltd Revenue in Erectile Dysfunction Treatment Drugs Business (2016-2021)
11.2.5 Dong-A Pharmaceutical Co. Ltd Recent Development
11.3 Vivus, Inc.
11.3.1 Vivus, Inc. Company Details
11.3.2 Vivus, Inc. Business Overview
11.3.3 Vivus, Inc. Erectile Dysfunction Treatment Drugs Introduction
11.3.4 Vivus, Inc. Revenue in Erectile Dysfunction Treatment Drugs Business (2016-2021)
11.3.5 Vivus, Inc. Recent Development
11.4 Meda Pharmaceuticals
11.4.1 Meda Pharmaceuticals Company Details
11.4.2 Meda Pharmaceuticals Business Overview
11.4.3 Meda Pharmaceuticals Erectile Dysfunction Treatment Drugs Introduction
11.4.4 Meda Pharmaceuticals Revenue in Erectile Dysfunction Treatment Drugs Business (2016-2021)
11.4.5 Meda Pharmaceuticals Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Erectile Dysfunction Treatment Drugs Introduction
11.5.4 Bayer AG Revenue in Erectile Dysfunction Treatment Drugs Business (2016-2021)
11.5.5 Bayer AG Recent Development
11.6 Johnson & Johnson Services
11.6.1 Johnson & Johnson Services Company Details
11.6.2 Johnson & Johnson Services Business Overview
11.6.3 Johnson & Johnson Services Erectile Dysfunction Treatment Drugs Introduction
11.6.4 Johnson & Johnson Services Revenue in Erectile Dysfunction Treatment Drugs Business (2016-2021)
11.6.5 Johnson & Johnson Services Recent Development
11.7 Apricus Biosciences
11.7.1 Apricus Biosciences Company Details
11.7.2 Apricus Biosciences Business Overview
11.7.3 Apricus Biosciences Erectile Dysfunction Treatment Drugs Introduction
11.7.4 Apricus Biosciences Revenue in Erectile Dysfunction Treatment Drugs Business (2016-2021)
11.7.5 Apricus Biosciences Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Erectile Dysfunction Treatment Drugs Introduction
11.8.4 Eli Lilly Revenue in Erectile Dysfunction Treatment Drugs Business (2016-2021)
11.8.5 Eli Lilly Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Erectile Dysfunction Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Phosphodiesterase Type 5 Inhibitors
Table 3. Key Players of Prostaglandin E1
Table 4. Global Erectile Dysfunction Treatment Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Erectile Dysfunction Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Erectile Dysfunction Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Erectile Dysfunction Treatment Drugs Market Share by Regions (2016-2021)
Table 8. Global Erectile Dysfunction Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Erectile Dysfunction Treatment Drugs Market Share by Regions (2022-2027)
Table 10. Erectile Dysfunction Treatment Drugs Market Trends
Table 11. Erectile Dysfunction Treatment Drugs Market Drivers
Table 12. Erectile Dysfunction Treatment Drugs Market Challenges
Table 13. Erectile Dysfunction Treatment Drugs Market Restraints
Table 14. Global Erectile Dysfunction Treatment Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Erectile Dysfunction Treatment Drugs Market Share by Players (2016-2021)
Table 16. Global Top Erectile Dysfunction Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erectile Dysfunction Treatment Drugs as of 2020)
Table 17. Ranking of Global Top Erectile Dysfunction Treatment Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Erectile Dysfunction Treatment Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Erectile Dysfunction Treatment Drugs Product Solution and Service
Table 21. Date of Enter into Erectile Dysfunction Treatment Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Erectile Dysfunction Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Erectile Dysfunction Treatment Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Erectile Dysfunction Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Erectile Dysfunction Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Erectile Dysfunction Treatment Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Erectile Dysfunction Treatment Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global Erectile Dysfunction Treatment Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Erectile Dysfunction Treatment Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Erectile Dysfunction Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Erectile Dysfunction Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Erectile Dysfunction Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Erectile Dysfunction Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Erectile Dysfunction Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Erectile Dysfunction Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Erectile Dysfunction Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Erectile Dysfunction Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Erectile Dysfunction Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Erectile Dysfunction Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Erectile Dysfunction Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Erectile Dysfunction Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Erectile Dysfunction Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Erectile Dysfunction Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Erectile Dysfunction Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Erectile Dysfunction Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Erectile Dysfunction Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Erectile Dysfunction Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Inc. Company Details
Table 62. Pfizer Inc. Business Overview
Table 63. Pfizer Inc. Erectile Dysfunction Treatment Drugs Product
Table 64. Pfizer Inc. Revenue in Erectile Dysfunction Treatment Drugs Business (2016-2021) & (US$ Million)
Table 65. Pfizer Inc. Recent Development
Table 66. Dong-A Pharmaceutical Co. Ltd Company Details
Table 67. Dong-A Pharmaceutical Co. Ltd Business Overview
Table 68. Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Drugs Product
Table 69. Dong-A Pharmaceutical Co. Ltd Revenue in Erectile Dysfunction Treatment Drugs Business (2016-2021) & (US$ Million)
Table 70. Dong-A Pharmaceutical Co. Ltd Recent Development
Table 71. Vivus, Inc. Company Details
Table 72. Vivus, Inc. Business Overview
Table 73. Vivus, Inc. Erectile Dysfunction Treatment Drugs Product
Table 74. Vivus, Inc. Revenue in Erectile Dysfunction Treatment Drugs Business (2016-2021) & (US$ Million)
Table 75. Vivus, Inc. Recent Development
Table 76. Meda Pharmaceuticals Company Details
Table 77. Meda Pharmaceuticals Business Overview
Table 78. Meda Pharmaceuticals Erectile Dysfunction Treatment Drugs Product
Table 79. Meda Pharmaceuticals Revenue in Erectile Dysfunction Treatment Drugs Business (2016-2021) & (US$ Million)
Table 80. Meda Pharmaceuticals Recent Development
Table 81. Bayer AG Company Details
Table 82. Bayer AG Business Overview
Table 83. Bayer AG Erectile Dysfunction Treatment Drugs Product
Table 84. Bayer AG Revenue in Erectile Dysfunction Treatment Drugs Business (2016-2021) & (US$ Million)
Table 85. Bayer AG Recent Development
Table 86. Johnson & Johnson Services Company Details
Table 87. Johnson & Johnson Services Business Overview
Table 88. Johnson & Johnson Services Erectile Dysfunction Treatment Drugs Product
Table 89. Johnson & Johnson Services Revenue in Erectile Dysfunction Treatment Drugs Business (2016-2021) & (US$ Million)
Table 90. Johnson & Johnson Services Recent Development
Table 91. Apricus Biosciences Company Details
Table 92. Apricus Biosciences Business Overview
Table 93. Apricus Biosciences Erectile Dysfunction Treatment Drugs Product
Table 94. Apricus Biosciences Revenue in Erectile Dysfunction Treatment Drugs Business (2016-2021) & (US$ Million)
Table 95. Apricus Biosciences Recent Development
Table 96. Eli Lilly Company Details
Table 97. Eli Lilly Business Overview
Table 98. Eli Lilly Revenue in Erectile Dysfunction Treatment Drugs Business (2016-2021) & (US$ Million)
Table 99. Eli Lilly Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Erectile Dysfunction Treatment Drugs Market Share by Type: 2020 VS 2027
Figure 2. Phosphodiesterase Type 5 Inhibitors Features
Figure 3. Prostaglandin E1 Features
Figure 4. Global Erectile Dysfunction Treatment Drugs Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Erectile Dysfunction Treatment Drugs Report Years Considered
Figure 9. Global Erectile Dysfunction Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Erectile Dysfunction Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Erectile Dysfunction Treatment Drugs Market Share by Regions: 2020 VS 2027
Figure 12. Global Erectile Dysfunction Treatment Drugs Market Share by Regions (2022-2027)
Figure 13. Global Erectile Dysfunction Treatment Drugs Market Share by Players in 2020
Figure 14. Global Top Erectile Dysfunction Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erectile Dysfunction Treatment Drugs as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Erectile Dysfunction Treatment Drugs Revenue in 2020
Figure 16. Global Erectile Dysfunction Treatment Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Global Erectile Dysfunction Treatment Drugs Revenue Market Share by Type (2022-2027)
Figure 18. North America Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Erectile Dysfunction Treatment Drugs Market Share by Type (2016-2027)
Figure 20. North America Erectile Dysfunction Treatment Drugs Market Share by Application (2016-2027)
Figure 21. North America Erectile Dysfunction Treatment Drugs Market Share by Country (2016-2027)
Figure 22. United States Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Erectile Dysfunction Treatment Drugs Market Share by Type (2016-2027)
Figure 26. Europe Erectile Dysfunction Treatment Drugs Market Share by Application (2016-2027)
Figure 27. Europe Erectile Dysfunction Treatment Drugs Market Share by Country (2016-2027)
Figure 28. Germany Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Erectile Dysfunction Treatment Drugs Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Erectile Dysfunction Treatment Drugs Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Erectile Dysfunction Treatment Drugs Market Share by Region (2016-2027)
Figure 38. China Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Erectile Dysfunction Treatment Drugs Market Share by Type (2016-2027)
Figure 46. Latin America Erectile Dysfunction Treatment Drugs Market Share by Application (2016-2027)
Figure 47. Latin America Erectile Dysfunction Treatment Drugs Market Share by Country (2016-2027)
Figure 48. Mexico Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Erectile Dysfunction Treatment Drugs Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Erectile Dysfunction Treatment Drugs Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Erectile Dysfunction Treatment Drugs Market Share by Country (2016-2027)
Figure 54. Turkey Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Inc. Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2016-2021)
Figure 58. Dong-A Pharmaceutical Co. Ltd Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2016-2021)
Figure 59. Vivus, Inc. Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2016-2021)
Figure 60. Meda Pharmaceuticals Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2016-2021)
Figure 61. Bayer AG Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2016-2021)
Figure 62. Johnson & Johnson Services Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2016-2021)
Figure 63. Apricus Biosciences Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2016-2021)
Figure 64. Eli Lilly Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界の勃起不全治療市場規模・現状・予測（2021年-2027年）

Global Erectile Dysfunction Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4204 2021年6月 122Pages
QYResearch社発行の本調査レポートでは、勃起不全治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口治療、陰茎インプラント、真空収縮装置、衝撃波療法）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、...

世界の女性性機能障害治療市場規模・現状・予測（2021年-2027年）

Global Female Sexual Dysfunction Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5740 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、女性性機能障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ホルモン療法、ホルモン療法）、用途別市場規模（性的欲求障害、性的覚醒障害、オルガスム障害、性的疼痛障害、オルガスム後疾患、骨盤底機能...

勃起不全（ED）薬のグローバル市場調査 2019年

Global Erectile Dysfunction(ED) Drug Market Professional Survey Report 2019
QYR9NV04483 2019年11月12日 103Pages
※本調査レポートは、勃起不全（ED）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、バルデナフィル、アバナフィル、タダラフィル、バルデナフィルに、用途別には...

世界のウイルス性肺炎治療薬市場規模・現状・予測（2021年-2027年）

Global Viral Pneumonia Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5025 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ウイルス性肺炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リバビリン、アシクロビル、ガンシクロビル、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模...

世界の副鼻腔炎治療薬市場規模・現状・予測（2021年-2027年）

Global Sinusitis Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6007 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、副鼻腔炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、NSAIDS、充血除去剤・粘液溶解剤、鼻洗浄キット）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の多発性嚢胞腎治療薬市場規模・現状・予測（2021年-2027年）

Global Polycystic Kidney Disease Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4730 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多発性嚢胞腎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ANG-3070、CIM-2、CR-8、その他）、用途別市場規模（常染色体優性多発性嚢胞腎（ADPKD）、常染色体劣性多発性嚢胞腎（A...

世界の遅発性ジスキネジア(TD)治療薬市場規模・現状・予測（2021年-2027年）

Global Tardive Dyskinesia (TD) Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6032 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、遅発性ジスキネジア(TD)治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バルベナジン、デュテトラベナジン）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の尿失禁治療薬市場規模・現状・予測（2021年-2027年）

Global Urinary Incontinence Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6059 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、尿失禁治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痙薬、筋弛緩薬、α遮断薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の糖尿病治療薬市場規模・現状・予測（2021年-2027年）

Global Diabetes Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5701 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、糖尿病治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、GLP-1、インスリン）、用途別市場規模（1型糖尿病、2型糖尿病）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の先天性インスリン過剰症治療薬市場規模・現状・予測（2021年-2027年）

Global Congenital Hyperinsulinism Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5672 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、先天性インスリン過剰症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ジアゾキシド、オクトレオチド、グルカゴン）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の勃起不全治療市場規模・現状・予測（2021年-2027年） Erectile dysfunction (ED) also known as impotence, refers to problems with achieving and maintaining erections.Currently available treatment for erectile dysfunction is oral therapy, usually with pde-5 inhibitors (sildenafil, tadalafil, avanafil and vardenafil), as well as penis implants, vacuum con…
勃起不全（ED）薬のグローバル市場調査 2019年 The global Erectile Dysfunction(ED) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Erectile Dysfunction(ED) Drug volume and value at global level, regional level and company level. From a glob…
世界の女性性機能障害治療市場規模・現状・予測（2021年-2027年） Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm. The increasing prevalence of chronic diseases is one of the key factors that will drive the growth of the market…
女性用性機能障害治療のグローバル市場：規模・現状・予測2019-2025 Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm. The increasing prevalence of chronic diseases is one of the key factors that will drive the growth of the market…
女性用性機能障害治療のグローバル市場：規模・現状・予測2019-2025 Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm. The increasing prevalence of chronic diseases is one of the key factors that will drive the growth of the market…